Genetically engineered bacterial magnetosomes as optimized tracers for magnetic particle imaging.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Medical Imaging

Background:

• Magnetic Particle Imaging (MPI) is a sensitive tomographic technique with high temporal resolution, promising for clinical applications like tumor detection and real-time imaging.
• Current MPI performance is limited by the quality of iron oxide nanoparticle tracers, as chemical synthesis offers restricted control over particle size, shape, and magnetic properties.
• Magnetosomes, biogenic magnetic nanoparticles produced by magnetotactic bacteria, offer uniform size and morphology due to their genetically encoded biosynthesis, presenting an alternative to chemical synthesis.

Purpose of the Study:

• To evaluate magnetosomes from genetically engineered Magnetospirillum gryphiswaldense mutant strains as potential MPI tracers.
• To compare the imaging performance of biogenic magnetosome tracers with conventional tracers.
• To demonstrate the potential of genetically tailored magnetosomes for improving MPI signal quality and advancing preclinical and clinical applications.

Main Methods:

• Isolation of magnetosomes from different Magnetospirillum gryphiswaldense mutant strains with varying core diameters.
• Characterization of magnetosome properties using Magnetic Particle Spectroscopy (MPS) to identify promising candidates based on signal properties.
• Detailed signal analysis and phantom experiments to directly compare the imaging performance of selected magnetosome tracers.

Main Results:

• Genetically engineered magnetosomes demonstrated superior MPI signal quality compared to conventional tracers.
• Precise control over magnetosome size, shape, and magnetic properties through genetic engineering allows for tailored tracer optimization.
• The study identified specific magnetosome characteristics that significantly enhance MPI performance.

Conclusions:

• Genetically tailored magnetosomes represent a promising next-generation tracer for Magnetic Particle Imaging.
• This biogenic approach offers significant advantages in controlling nanoparticle properties for optimized MPI performance.
• The findings provide a foundation for the rational design of biogenic nanoparticles to advance MPI technology for clinical translation.